Barings 13F: New $2.7M Stake in JBS

JBS N.V. (JBS) business photo

Key Points

  • Barings initiated a new position in JBS N.V. (NYSE:JBS) by acquiring 240,060 shares valued at approximately $2,710,277.
  • JBS N.V. offers an annual dividend rate of $1.00 per share with an 8.02% dividend yield and a payout ratio of 93.5%.
  • Other large investment managers adjusted their positions recently, including Davis Selected Advisers growing its stake by 23,772,016 shares.

Get JBS N.V. text alerts

We text you when insiders, Congress, analysts or big funds move on $JBS.

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated JBS N.V. alert may contain errors. Disclosures

Barings opened a new position in JBS N.V. (NYSE:JBS) by purchasing 240,060 shares, according to a Form 13F filing with the SEC on October 22, 2026. The newly acquired stake carried a reported value of about $2.7 million at the time of the filing. Institutional investment managers like Barings disclose their quarterly stock holdings through these filings to reveal portfolio shifts.

JBS JBS N.V.
$12.22 -6.93% year to date
Daily close · Oct 22, 2026

What Changed in Barings's JBS N.V. Position

Barings established a fresh stake in the packaged foods producer, going from zero shares to 240,060 shares. The investment was valued at $2,710,277 based on the reported filing data.

Other Institutional Activity in JBS N.V.

Other large institutional investors also adjusted their positions in the company. Bndes Participacoes S.A. trimmed its holdings by 19,931 shares, ending with 199,288,206 shares worth about $2.5 billion. Davis Selected Advisers grew its holdings by 23,772,016 shares, ending with 50,016,236 shares worth about $618.7 million for a 90.6% increase. Shaw D.E. & Co., Inc. lifted its stake by 4,886,385 shares, finishing with 11,276,322 shares valued at approximately $139.5 million following a 76.5% increase. Brandes Investment Partners L.P. added 4,711,186 shares to end with 7,693,893 shares worth about $95.2 million, a 157.9% jump. Ameriprise Financial, Inc. shed 10,057 shares, leaving it with 6,694,797 shares valued at about $82.8 million.

JBS N.V. Stock Down 4.0%

The shares recently traded around $11.96 as of October 22, 2026. The stock sits below its 50-day and 200-day moving averages and holds well below its 52-week high of $18.65, though it trades above its 52-week low of $10.61.

Recent Earnings

JBS N.V. posted trailing-twelve-month revenue of $91.2 billion alongside $1.07 in earnings per share. The company operates with a net profit margin of 1.2% and a return on equity of 13.4%. Its next earnings report is scheduled for November 9, 2026.

Dividend

JBS N.V. distributes an annual dividend rate of $1.00 per share. This payout translates to an 8.02% dividend yield based on recent trading levels. The company's dividend payout ratio sits at 93.5%.

Insider Buying and Selling at JBS N.V.

Guilherme Perboyre Cavalcanti, an officer at the company, sold 183,501 shares on August 24, 2026. The transaction took place at an average price of $13.85, coming to a total value of about $2.5 million.

Analysts Set New Price Targets

Wall Street firms updated their views on the stock ahead of the filing. JP Morgan maintained an Overweight rating on August 12 with a $17.50 price target. Stephens & Co. kept an Overweight rating on August 17 with a $17.00 target. UBS maintained a Buy rating on August 24 and moved its target to $17.50. JP Morgan later reiterated an Overweight rating on October 9 with an $18.00 target, followed by another update on October 22 maintaining the Overweight rating while adjusting the target to $17.50. The stock currently carries a consensus buy recommendation from 15 analysts with a mean price target of $18.43.

About JBS N.V.

JBS N.V. processes animal proteins worldwide, handling beef, pork, lamb, and poultry. The company also prepares food products and operates related businesses involving leather, collagen, biodiesel, and metal packaging out of its headquarters in Amstelveen, Netherlands.

Bottom Line

Investors will watch for the company's upcoming earnings release on November 9, 2026, to gauge profitability and operational margins. Institutional ownership shifts will continue to surface through subsequent SEC disclosures.

Source: Barings's 13F filing on $JBS (Oct 22, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts

Get $JBS trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions